Sanmina Corporation
SANM
$216.00
+6.24%
Sanmina Corporation is a leading provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers (OEMs) across communications networks, storage, industrial, defense, and aerospace end markets. The company operates through two primary segments: Integrated Manufacturing Solutions (IMS), which focuses on printed circuit board assembly and represents the majority of revenue, and Components, Products, and Services (CPS), which includes interconnect and mechanical systems. Sanmina is recognized as a top-tier electronics manufacturing services (EMS) provider, competing with industry giants like Jabil and Flex, and differentiates itself through its engineering capabilities and diversified end-market exposure. The current investor narrative centers on the company's robust revenue growth, driven by strong demand in communications and defense, alongside margin expansion initiatives and a strategic focus on higher-value services, which has fueled a significant stock rally over the past year. However, recent volatility and a sharp pullback from all-time highs have raised questions about valuation sustainability and the pace of future growth.…
SANM
Sanmina Corporation
$216.00
Related headlines
Investment Opinion: Should I buy SANM Today?
Based on the analysis, SANM is rated a Buy. The thesis is that Sanmina's explosive revenue growth and margin expansion are undervalued by the market, as evidenced by a forward PE of 14.26x versus the sector average of 22x. With an average analyst target of $260, implying 31% upside, and a low target of $210 offering 6% upside, the risk-reward is favorable.
Sign up to view all
SANM 12-Month Price Forecast
The AI assessment is bullish on SANM, driven by exceptional revenue growth and margin improvements that are not fully reflected in the forward valuation. The stock's low forward PE relative to its growth prospects suggests upside potential. However, confidence is medium due to the sustainability of growth and limited analyst coverage. If revenue growth continues at a high rate and margins hold, the stock could re-rate higher. Conversely, any signs of deceleration or margin erosion would warrant a downgrade to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sanmina Corporation's 12-month outlook, with a consensus price target around $260.00 and implied upside of +20.4% versus the current price.
Average Target
$260.00
0 analysts
Implied Upside
+20.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$210 - $300
Analyst target range
Analyst coverage on Sanmina is limited, with only 4 analysts providing ratings, which is typical for a mid-cap company. The consensus recommendation is 'none', but the distribution includes 1 Buy (Argus Research) and 3 Neutral/Hold ratings (B of A Securities, Craig-Hallum). The average target price is $260.00, implying an upside of 31.0% from the current price of $198.47. This suggests a moderately bullish sentiment, but the lack of a clear consensus indicates uncertainty. The target price range is wide, from a low of $210.00 to a high of $300.00, reflecting a 42.9% spread between the low and high targets. The high target of $300 assumes continued strong growth and margin expansion, potentially driven by new program wins and AI-related demand, while the low target of $210 factors in potential margin pressures and cyclicality in the EMS industry. Recent institutional ratings show a mix of actions, with Argus maintaining a Buy in January 2026, while B of A Securities has held a Neutral stance since 2025, and Craig-Hallum downgraded from Buy to Hold in April 2024, indicating a cautious but not bearish outlook. The wide target range and limited coverage suggest higher uncertainty and potential volatility in the stock.
Bulls vs Bears: SANM Investment Factors
Sanmina presents a compelling growth story with explosive revenue growth, improving margins, and a reasonable forward valuation. However, the stock's sharp pullback from highs, thin margins, and limited analyst coverage introduce significant uncertainty. Currently, the bull case has stronger evidence given the fundamental inflection and attractive forward PE, but the key tension is whether the revenue surge is sustainable or a one-time event. If growth normalizes, the stock could face de-rating, while continued momentum could drive it toward analyst high targets.
Bullish
- Explosive Revenue Growth: Q2 FY2026 revenue surged 102.27% YoY to $4.013 billion, a dramatic acceleration from the ~$2.0 billion run-rate in prior quarters. This inflection likely reflects major new program wins or acquisitions, signaling strong demand across communications, defense, and industrial markets.
- Margin Expansion Driving Profitability: Operating margin improved to 5.74% in Q2 FY2026 from 3.69% in Q1, while net margin rose to 2.33% from 1.55%. This demonstrates operational leverage and better cost control, which is critical in the low-margin EMS industry.
- Attractive Forward Valuation: With a forward PE of 14.26x versus trailing PE of 25.02x, the market expects significant EPS growth (analyst estimate $15.70 for FY2026). This forward multiple is below the sector average of 22x, suggesting the stock is undervalued relative to its growth prospects.
- Strong Balance Sheet: Debt-to-equity is only 0.167, and the current ratio is 1.72, indicating a solid liquidity position. This financial stability provides flexibility for investments, acquisitions, or weathering cyclical downturns.
Bearish
- Sharp Pullback from Highs: The stock has fallen over 30% from its 52-week high of $288.68 to $198.47, and is down 21.27% over the past three months. This significant correction may indicate waning momentum or concerns about sustainability of growth.
- Thin Gross Margins: Gross margin is only 8.82% in Q2 FY2026, reflecting the highly competitive and low-margin nature of EMS. Even with operating leverage, net margin remains just 2.33%, leaving little room for error or cost inflation.
- Limited Analyst Coverage: Only 4 analysts cover SANM, with 3 Neutral/Hold ratings and just 1 Buy. The lack of a clear consensus and wide target range ($210-$300) indicates high uncertainty and potential for volatility.
- High Beta and Volatility: With a beta of 1.6, SANM is significantly more volatile than the market. The stock's max drawdown of -42.05% over the past year highlights the risk of sharp declines, which could be exacerbated in a market downturn.
SANM Technical Analysis
Sanmina's stock has exhibited a powerful long-term uptrend, with a 1-year price change of +65.58%, significantly outperforming the S&P 500's +18.65% over the same period. The current price of $198.47 sits at approximately 68.7% of the 52-week range (between $110.44 and $288.68), indicating a pullback from the highs but still well above the lows. This positioning suggests the stock is in a corrective phase within a broader bull market, rather than a breakdown, as it remains above the 50% retracement level of the range. The 52-week high of $288.68 was reached in June 2026, and the subsequent decline has been sharp, with the stock losing over 30% from that peak, yet it has found some support near the $185-$190 area in late August.
Beta
1.60
1.60x market volatility
Max Drawdown
-42.0%
Largest decline past year
52-Week Range
$110-$289
Price range past year
Annual Return
+83.4%
Cumulative gain past year
| Period | SANM Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | -1.1% |
| 3m | -15.4% | +3.0% |
| 6m | +72.5% | +15.4% |
| 1y | +83.4% | +16.2% |
| ytd | +35.6% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SANM Fundamental Analysis
Sanmina's revenue trajectory has been robust, with the most recent quarter (Q2 FY2026, ending March 28, 2026) reporting revenue of $4.013 billion, a 102.27% year-over-year increase, driven by strong demand across its end markets. This growth represents a significant acceleration from the prior quarters, where revenue was around $2.0 billion, indicating a major inflection point, likely due to new program ramps or acquisitions. The company's gross margin, however, remains thin at 8.82% in the latest quarter, reflecting the competitive nature of the EMS industry, but it has improved slightly from 7.56% in the prior quarter. Net income for the quarter was $93.6 million, yielding a net margin of 2.33%, up from 1.55% in Q1 FY2026, showing improving profitability despite the low-margin nature of the business. The company has been able to expand its operating margin to 5.74% in Q2 FY2026, up from 3.69% in Q1, indicating better cost control and operational leverage.
Quarterly Revenue
$4.0B
2026-03
Revenue YoY Growth
+102.3%
YoY Comparison
Gross Margin
8.8%
Latest Quarter
Free Cash Flow
$734234000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SANM Overvalued?
Given Sanmina's positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE stands at 25.02x, while the forward PE is 14.26x, implying that the market expects significant earnings growth in the coming year. This gap between trailing and forward multiples suggests that the market is pricing in a substantial increase in EPS, which is supported by analyst estimates of $15.70 for the current fiscal year, up from the trailing EPS of approximately $7.93. The forward PE of 14.26x is below the sector average, indicating that the stock may be undervalued relative to its growth prospects, especially when considering its PEG ratio of 1.79, which is above 1 but not excessively high. Compared to the industry average PE of 22x (from valuation data), Sanmina's trailing PE of 25x represents a 13.6% premium, but this is justified by its superior revenue growth and improving margins. Historically, Sanmina's PE has ranged from as low as 5.4x in 2021 to as high as 42.4x in Q1 FY2026, and the current trailing PE of 25x is near the middle of this range, suggesting that the stock is not extremely overvalued or undervalued relative to its own history.
PE
25.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~19x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Sanmina's thin gross margin of 8.82% leaves little buffer against cost increases or pricing pressure, and its net margin of 2.33% means profitability is highly sensitive to operational execution. The company's debt-to-equity is low at 0.167, but the recent revenue surge may have been fueled by acquisitions or new programs that carry integration risks. Additionally, the reliance on continued high growth to justify the forward PE of 14.26x means any slowdown could lead to earnings disappointment and multiple compression.
FAQ
The key risks include: 1) Financial risk: thin gross margins of 8.82% leave little room for cost increases, and any margin compression could significantly impact net income. 2) Market risk: with a beta of 1.6, the stock is highly sensitive to market movements, and a downturn could lead to outsized losses. 3) Competitive risk: the EMS industry is highly competitive, and Sanmina could lose market share to larger players like Jabil or Flex. 4) Company-specific risk: the recent revenue surge may be tied to a single customer or program, and losing that business could cause a sharp decline. The most severe risk is a combination of these factors leading to a drop towards the 52-week low of $110.44, representing a -44% loss from current levels.
The 12-month forecast is bullish, with a base case target of $220-$260 (50% probability), a bull case of $260-$300 (25% probability), and a bear case of $160-$210 (25% probability). The most likely scenario is the base case, which assumes revenue growth normalizes but remains strong, and margins continue to improve. The average analyst target is $260, implying 31% upside. Key factors to watch are the sustainability of revenue growth and margin expansion.
Based on forward earnings, SANM appears undervalued with a forward PE of 14.26x, which is below the sector average of 22x. The trailing PE of 25.02x is above the sector, but this is due to the recent earnings surge that has not yet been fully reflected in annualized EPS. The PEG ratio of 1.79 suggests the stock is fairly valued relative to its growth rate. Historically, the PE has ranged from 5.4x to 42.4x, so the current level is in the middle. Overall, the market is pricing in significant growth, but the forward multiple suggests there is still room for upside if the company delivers.
SANM appears to be a good buy for growth-oriented investors given its explosive revenue growth of 102% YoY and forward PE of 14.26x, which is below the sector average. The average analyst target of $260 implies 31% upside, and even the low target of $210 offers some upside. However, the stock is volatile with a beta of 1.6 and has pulled back over 30% from its highs, so it is not without risk. It may be suitable for investors who can tolerate short-term fluctuations and have a 12-month or longer horizon.
SANM is more suitable for long-term investment (3-5 years) given its growth trajectory and improving fundamentals. The stock has high volatility (beta 1.6) and has experienced a max drawdown of -42%, making it risky for short-term trading. However, the forward PE of 14.26x suggests that the market expects significant earnings growth, which could take time to materialize. Investors should have a minimum holding period of at least 12 months to allow the growth story to play out, and ideally longer to ride out market cycles.